Press Room - Sanofi US News

Media Room Menu

Jul 27, 2016

Sanofi Receives FDA Approval of Adlyxin™ for Treatment of Adults with Type 2 Diabetes

- Adlyxin™ is approved as Lyxumia® in more than 60 countries -
Jul 26, 2016

Sanofi Pasteur Ships First of its 2016-2017 Seasonal Influenza Vaccine Doses in United States

- World's largest influenza vaccine manufacturer expects to distribute more than 65 million vaccine doses to help protect people six months and older against the flu -
Jul 20, 2016

Surveys Find Adults with Type 2 Diabetes Are More Willing to Take Action to Achieve A1C Targets Quicker than Physicians and Other Medical Professionals Perceive

-- Findings reveal that some patients are frustrated and discontinued medication because they were not reaching their individualized A1C target quick enough --
Jul 12, 2016

Award-Winning Chef Elizabeth Falkner Reveals Her Struggle with Atopic Dermatitis to Highlight the Physical and Psychological Impact of the Disease

Falkner has joined forces with Regeneron and Sanofi Genzyme in collaboration with leading dermatology organizations to educate Americans about a potentially serious, chronic inflammatory skin disease known as atopic dermatitis.
Jun 12, 2016

Sanofi Announces Positive Phase 3 Results for Investigational Titratable Fixed-Ratio Combination of Insulin Glargine and Lixisenatide

- Both pivotal studies demonstrated superior reduction in HbA1c versus insulin glargine and versus lixisenatide -

Show per page